Mohamed Hamdi
YOU?
Author Swipe
View article: A Numerical Case Study on the Design of a Multi-Porosity Heat Exchanger for VRF Air Conditioning Applications
A Numerical Case Study on the Design of a Multi-Porosity Heat Exchanger for VRF Air Conditioning Applications Open
This study proposes a novel multi-porous heat exchanger (MPHEX) as a passive, sustainable alternative to variable refrigerant flow (VRF) air conditioning systems, addressing the growing environmental burden of cooling demand. Through high-…
View article: Power-to-hydrogen: A review of applications, market development, and policy landscape
Power-to-hydrogen: A review of applications, market development, and policy landscape Open
As a result of the shift to low-carbon sustainable energy systems, hydrogen is now a major energy carrier. With an emphasis on hydrogen generation, storage, applications, infrastructure development and policy landscape, this review examine…
View article: SafetyRAG: Towards Safe Large Language Model-Based Application through Retrieval-Augmented Generation
SafetyRAG: Towards Safe Large Language Model-Based Application through Retrieval-Augmented Generation Open
View article: Techno-environmental optimal sizing and dynamic behavior of a hybrid system feeding a large-scale SWRO desalination system: The case of Djerba Island, Tunisia
Techno-environmental optimal sizing and dynamic behavior of a hybrid system feeding a large-scale SWRO desalination system: The case of Djerba Island, Tunisia Open
The environment, energy, and water are the three essential pillars of sustainable development. In light of the freshwater scarcity faced by numerous countries, desalination emerges as a practical solution. As a result, countries are increa…
View article: Optimized system for combined production of electricity/green hydrogen for multiple energy pathways: a case study of Egypt
Optimized system for combined production of electricity/green hydrogen for multiple energy pathways: a case study of Egypt Open
By optimal sizing of a wind/photovoltaic hybrid renewable-energy (RE) system, trimming the surplus capacity to reduce the fluctuations in the electricity supplied to the grid, and using it to produce green hydrogen through electrolysis, a …
View article: Thermal assessment of cylindrical parabolic integrated collector storage using input-output and dynamic system testing procedures: Experimental and numerical study
Thermal assessment of cylindrical parabolic integrated collector storage using input-output and dynamic system testing procedures: Experimental and numerical study Open
The main limitation of Integrated Collector Storage systems lies in their low efficiencies and high loss coefficients. In this paper, experimental and numerical setups are conducted to assess the thermal performances of low cost Cylindrica…
View article: Dynamic testing of a new integrated collector storage solar water heater (<scp>ICSSWH</scp>) according to standard <scp>ISO</scp> 9459‐5: Use of a numerical approach for long‐term prediction in different climatic conditions
Dynamic testing of a new integrated collector storage solar water heater (<span>ICSSWH</span>) according to standard <span>ISO</span> 9459‐5: Use of a numerical approach for long‐term prediction in different climatic conditions Open
This work analyzes the performance of a new Integrated Collector Storage Solar Water Heater (ICSSWH) by using Dynamic System Testing (DST) method according to Standard ISO 9459‐5. The long‐term performance study of the system in different …
View article: Data from Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors
Data from Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors Open
Cancer therapy frequently fails due to the emergence of resistance. Many tumors include phenotypically immature tumor cells, which have been implicated in therapy resistance. Neuroblastoma cells can adopt a lineage-committed adrenergic (AD…
View article: Supplementary Data from Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors
Supplementary Data from Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors Open
Supplementary Data from Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors
View article: Supplementary Data from Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors
Supplementary Data from Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors Open
Supplementary Data from Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors
View article: Supplementary Data from Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors
Supplementary Data from Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors Open
Supplementary Data from Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors
View article: Supplementary Data from Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors
Supplementary Data from Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors Open
Supplementary Data from Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors
View article: Data from Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors
Data from Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors Open
Cancer therapy frequently fails due to the emergence of resistance. Many tumors include phenotypically immature tumor cells, which have been implicated in therapy resistance. Neuroblastoma cells can adopt a lineage-committed adrenergic (AD…
View article: Supplementary Table 2 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene
Supplementary Table 2 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene Open
Supplementary Table 2 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
View article: Supplementary Figure Legends 1-6, Tables 1-2 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene
Supplementary Figure Legends 1-6, Tables 1-2 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene Open
Supplementary Figure Legends 1-6, Tables 1-2 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
View article: Supplementary Figure 4 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene
Supplementary Figure 4 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene Open
Supplementary Figure 4 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
View article: Data from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene
Data from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene Open
RAS oncogenes are among the most frequently mutated genes in human cancer, but effective strategies for therapeutic inhibition of the RAS pathway have been elusive. Sprouty1 (SPRY1) is an upstream antagonist of RAS tha…
View article: Supplementary Figure 4 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene
Supplementary Figure 4 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene Open
Supplementary Figure 4 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
View article: Supplementary Table 2 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene
Supplementary Table 2 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene Open
Supplementary Table 2 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
View article: Supplementary Figure 3 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene
Supplementary Figure 3 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene Open
Supplementary Figure 3 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
View article: Supplementary Figure 1 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene
Supplementary Figure 1 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene Open
Supplementary Figure 1 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
View article: Supplementary Table 1 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene
Supplementary Table 1 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene Open
Supplementary Table 1 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
View article: Supplementary Figure 2 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene
Supplementary Figure 2 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene Open
Supplementary Figure 2 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
View article: Supplementary Figure 2 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene
Supplementary Figure 2 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene Open
Supplementary Figure 2 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
View article: Supplementary Figure 6 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene
Supplementary Figure 6 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene Open
Supplementary Figure 6 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
View article: Data from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene
Data from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene Open
RAS oncogenes are among the most frequently mutated genes in human cancer, but effective strategies for therapeutic inhibition of the RAS pathway have been elusive. Sprouty1 (SPRY1) is an upstream antagonist of RAS tha…
View article: Supplementary Figure Legends 1-6, Tables 1-2 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene
Supplementary Figure Legends 1-6, Tables 1-2 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene Open
Supplementary Figure Legends 1-6, Tables 1-2 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
View article: Supplementary Figure 5 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene
Supplementary Figure 5 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene Open
Supplementary Figure 5 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
View article: Supplementary Figure 3 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene
Supplementary Figure 3 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene Open
Supplementary Figure 3 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
View article: Supplementary Figure 1 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene
Supplementary Figure 1 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene Open
Supplementary Figure 1 from Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene